#CA4UPSC HLL Biotech enters into agreement with Institute of Immunology,Croatia: HLL Biotech Limited, a subsidiary of Central Public Sector miniratna company HLL Lifecare Limited has entered into a long-term supply and technology transfer agreement with the Institute of Immunology, Zagreb, Croatia for mass production of measles vaccine in India. HLL Lifecare Limited Chairman Dr.M.Ayyappan said the company will produce 80 million doses of measles vaccine, for the Indian market, which will meet a major share of the Government requirements. The partnership will lead to the development of the next generation of vaccines, he said. Construction work has begun on Hindustan Biotech’s Integrated Vaccine Complex at Chengalpet in Tamil Nadu at a cost of 594 crore rupees. He said the Vaccine Complex would become fully operative by the end of 2016. JOIN our official; website: ceribrate
Posted on: Sun, 01 Sep 2013 09:09:56 +0000
Trending Topics
Recently Viewed Topics
© 2015